Pancreatic Cancer Research

ResearcherChiba UniversityActive in the last 2 years

Taku Higashihara

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9765-2034; OpenAlex author ID A5091821489. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
30
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 2 papers · 2026: 2 papers

Papers 7

  1. Coexisting Sarcoid Reaction and Sarcoidosis Requiring Differentiation from Pancreatic Adenocarcinoma Recurrence: A Case Report. Co-author DOI 10.70352/scrj.cr.25-0670↗
  2. Exceptional Long-Term Survival after Resection of Metachronous Liver and Lung Metastases Following Surgery for Pancreatic Cancer: A Case Report. Co-author DOI 10.70352/scrj.cr.26-0115↗
  3. Liver metastasis surgery followed by radical treatment for pancreatic ductal adenocarcinoma: A case report. Co-author DOI 10.3892/mco.2025.2905↗
  4. Long-Term Survival after Curative Resection for Postoperative Dissemination of Pancreatic Ductal Adenocarcinoma: A Case Report. Co-author DOI 10.70352/scrj.cr.24-0022↗
  5. MYC Levels Regulate Metastatic Heterogeneity in Pancreatic Adenocarcinoma. Co-author DOI 10.1158/2159-8290.cd-20-1826↗
  6. [Pancreas Bed Recurrence Resection Combined with Celiac and Common Hepatic Arterial Resection after Distal Pancreatectomy for Pancreatic Cancer]. Co-author PMID 29362327↗
  7. Sex Determining Region Y Box 9 Induces Chemoresistance in Pancreatic Cancer Cells by Induction of Putative Cancer Stem Cell Characteristics and Its High Expres… Co-author DOI 10.1097/mpa.0000000000000945↗

Closest collaborators

The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Taiki Tsuji · 3 shared papers, 2025–2026 · strength 0.75
  2. Makoto Takahashi · 3 shared papers, 2025–2026 · strength 0.75
  3. Yasuhiro Morita · 2 shared papers, 2025 · strength 0.51
  4. Dai Inoue · 2 shared papers, 2025–2026 · strength 0.50
  5. Yasuhiro Morita · 2 shared papers, 2026 · strength 0.49
  6. Masayuki Ohtsuka · 3 shared papers, 2017–2025 · strength 0.41
  7. Takeshi Azuma · 1 shared paper, 2025 · strength 0.26
  8. Yoshitaka Shimamaki · 1 shared paper, 2025 · strength 0.26
  9. Ryohei Horie · 1 shared paper, 2026 · strength 0.25
  10. Takumi Miwa · 1 shared paper, 2026 · strength 0.24
  11. Masaru Miyazaki · 2 shared papers, 2017–2018 · strength 0.15
  12. Hideyuki Yoshitomi · 2 shared papers, 2017–2018 · strength 0.15
  13. David Balli · 1 shared paper, 2022 · strength 0.10
  14. Robert J. Norgard · 1 shared paper, 2022 · strength 0.10
  15. John Christopher McAuliffe · 1 shared paper, 2022 · strength 0.10
  16. Pichai Raman · 1 shared paper, 2022 · strength 0.10
  17. Jinyang Li · 1 shared paper, 2022 · strength 0.10
  18. Ravikanth Maddipati · 1 shared paper, 2022 · strength 0.10
  19. Scott W. Lowe · 1 shared paper, 2022 · strength 0.10
  20. Timour Baslan · 1 shared paper, 2022 · strength 0.10
  21. Ben Z. Stanger · 1 shared paper, 2022 · strength 0.10
  22. Erica L. Carpenter · 1 shared paper, 2022 · strength 0.10
  23. Christine A. Iacobuzio–Donahue · 1 shared paper, 2022 · strength 0.10
  24. Jason Robert Pitarresi · 1 shared paper, 2022 · strength 0.10
  25. Faiyaz Notta · 1 shared paper, 2022 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.